fashion -WSS

fashion

author：entertainment 2025-09-07 11:09:05 - browse：1453

Jennifer Doudna Feng Zhang CRISPR — CRISPR pioneers Jennifer Doudna and Feng Zhang Illustration: STAT; Photos: AP, Getty

The revolution started in silence.

Jennifer Doudna and Emmanuelle Charpentier, now Nobelists, published their first paper announcing a new enzyme for editing DNA in Science in June 2012. It was called CRISPR-Cas9. It wasn’t until January 2013 that the first paper showing the enzyme would work in cells, from Feng Zhang, was published, also in Science. A similar paper from George Church came out at the same time.

No major media outlet covered the papers. The first story on CRISPR was published that March. But within the ivory tower of academia, it was clear something big was building, as requests for the technology poured in from other researchers and Zhang set up an assembly line in his laboratory to distribute it, with students carrying carefully packed samples to a FedEx office down the street.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Medicare has a new plan to address drug shortages

WSS

Why the advice to take all your antibiotics may be wrong

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

Hey, doctors: Don't be no

Sanders adds drug shortage policies to pandemic preparedness bill

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

Custom gene therapy hints at new path for rare disease treatments

knowledge

fashion

explore

Peter Hotez and the public health issue of online harassment

Biden White House, tech companies launch new safeguards around emerging AI technology

After affirmative action ruling, medical educators look to 'holistic review'

In early work, researchers turn to CRISPR to treat Alzheimer's

In Memoriam: Notable people who died in 2023

AI can’t replace a physician’s gut feeling

Continuity nursing helped my family in our darkest PICU moments

As digital health tech proliferates, a new institute aims to cut through hype

At least 13 dead in Texas as scorching temps continue

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

focus

Prosecutors say FTX founder Sam Bankman

How Brent Saunders' Allergan experiment failed

Pfizer's RSV vaccine recommended for approval in Europe

Biden tests positive for Covid

Doctors find melanoma drugs effective against rare brain cancer

As digital health tech proliferates, a new institute aims to cut through hype

hotspot

focus

explore

leisure time